Anti-Diabetic Agents
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
SAXAGLIPTIN: products 1 to 6 of 6.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Saxagliptin 2.5mg TabDIN 02507471 | General benefit | $1.2650per source unit | Requirements & sourcesBuild cost plan |
| Apo-Saxagliptin 5mg TabDIN 02507498 | General benefit | $1.5195per source unit | Requirements & sourcesBuild cost plan |
| Onglyza 2.5mg TabDIN 02375842 | General benefit | $1.2650per source unit | Requirements & sourcesBuild cost plan |
| Onglyza 5mg TabDIN 02333554 | General benefit | $1.5195per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Saxagliptin 2.5mg TabDIN 02468603 | General benefit | $1.2650per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Saxagliptin 5mg TabDIN 02468611 | General benefit | $1.5195per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).